{"id":"https://openalex.org/W2018680913","doi":"https://doi.org/10.1016/j.ctrv.2014.05.003","title":"Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms","display_name":"Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms","publication_year":2014,"publication_date":"2014-05-17","ids":{"openalex":"https://openalex.org/W2018680913","doi":"https://doi.org/10.1016/j.ctrv.2014.05.003","mag":"2018680913","pmid":"https://pubmed.ncbi.nlm.nih.gov/24867380"},"language":"en","primary_location":{"id":"doi:10.1016/j.ctrv.2014.05.003","doi":"https://doi.org/10.1016/j.ctrv.2014.05.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2014.05.003","pdf_url":null,"source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064694714","display_name":"Sariah Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sariah Liu","raw_affiliation_strings":["Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States. Electronic address: ssl054@ucsd.edu","Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States. Electronic address: ssl054@ucsd.edu","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]},{"raw_affiliation_string":"Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology and Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, United States","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064694714"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":4910,"currency":"USD","value_usd":4910},"apc_paid":null,"fwci":3.532,"has_fulltext":false,"cited_by_count":159,"citation_normalized_percentile":{"value":0.9679803,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"40","issue":"7","first_page":"883","last_page":"891"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5551999807357788,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5551999807357788,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.3086000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.026000000536441803,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-therapy-toxicity","display_name":"targeted therapy toxicity","score":0.9449999928474426},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6660000085830688},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7540000081062317},{"id":"https://openalex.org/keywords/on-target-toxicity","display_name":"on-target toxicity","score":0.8740000128746033},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.5289999842643738},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.3540000021457672},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.7450000047683716},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7990000247955322},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/immune-related-toxicity","display_name":"immune-related toxicity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8510394096374512},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7103047966957092},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.53183913230896},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5162293910980225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4973328411579132},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4669695198535919},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4601811170578003},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4549640119075775},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.45218580961227417},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.4516453444957733},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4257693886756897},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3632790744304657},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2816934585571289},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2527936100959778},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20195719599723816},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15485304594039917}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ctrv.2014.05.003","doi":"https://doi.org/10.1016/j.ctrv.2014.05.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2014.05.003","pdf_url":null,"source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},{"id":"pmid:24867380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24867380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":100,"referenced_works":["https://openalex.org/W1527084913","https://openalex.org/W1544089991","https://openalex.org/W1580209680","https://openalex.org/W1630248744","https://openalex.org/W1933440621","https://openalex.org/W1963485775","https://openalex.org/W1964591874","https://openalex.org/W1968909791","https://openalex.org/W1970255472","https://openalex.org/W1970263079","https://openalex.org/W1971811939","https://openalex.org/W1977379029","https://openalex.org/W1979425617","https://openalex.org/W1979937839","https://openalex.org/W1980758201","https://openalex.org/W1980843814","https://openalex.org/W1988379285","https://openalex.org/W1991236371","https://openalex.org/W1994606873","https://openalex.org/W1997192168","https://openalex.org/W1997499809","https://openalex.org/W1998462298","https://openalex.org/W2004942295","https://openalex.org/W2013865180","https://openalex.org/W2014198295","https://openalex.org/W2016773699","https://openalex.org/W2024545736","https://openalex.org/W2027114592","https://openalex.org/W2028031291","https://openalex.org/W2029722796","https://openalex.org/W2031520822","https://openalex.org/W2041066142","https://openalex.org/W2042278402","https://openalex.org/W2047170687","https://openalex.org/W2049480002","https://openalex.org/W2056047836","https://openalex.org/W2056802932","https://openalex.org/W2062426517","https://openalex.org/W2068937134","https://openalex.org/W2070232725","https://openalex.org/W2071549019","https://openalex.org/W2072674580","https://openalex.org/W2073990067","https://openalex.org/W2075457174","https://openalex.org/W2076017354","https://openalex.org/W2076186508","https://openalex.org/W2077246243","https://openalex.org/W2080669049","https://openalex.org/W2081365397","https://openalex.org/W2083729029","https://openalex.org/W2085861712","https://openalex.org/W2086706326","https://openalex.org/W2089714132","https://openalex.org/W2090628379","https://openalex.org/W2094882473","https://openalex.org/W2096134439","https://openalex.org/W2096560531","https://openalex.org/W2097121246","https://openalex.org/W2100738068","https://openalex.org/W2107561358","https://openalex.org/W2108923852","https://openalex.org/W2114553148","https://openalex.org/W2119404465","https://openalex.org/W2122074158","https://openalex.org/W2123029393","https://openalex.org/W2124201452","https://openalex.org/W2126390772","https://openalex.org/W2126621994","https://openalex.org/W2127180214","https://openalex.org/W2127498682","https://openalex.org/W2128402577","https://openalex.org/W2129171769","https://openalex.org/W2129400742","https://openalex.org/W2130022429","https://openalex.org/W2130244550","https://openalex.org/W2130986759","https://openalex.org/W2131705241","https://openalex.org/W2131754429","https://openalex.org/W2132733985","https://openalex.org/W2134758896","https://openalex.org/W2136871952","https://openalex.org/W2137367718","https://openalex.org/W2138792039","https://openalex.org/W2142287269","https://openalex.org/W2147930289","https://openalex.org/W2151730005","https://openalex.org/W2154896031","https://openalex.org/W2161482321","https://openalex.org/W2163278353","https://openalex.org/W2166480231","https://openalex.org/W2167646314","https://openalex.org/W2167738527","https://openalex.org/W2168143310","https://openalex.org/W2169631942","https://openalex.org/W2315082777","https://openalex.org/W2322508060","https://openalex.org/W2405151655","https://openalex.org/W3011465406","https://openalex.org/W4285719527","https://openalex.org/W6713577214"],"related_works":["https://openalex.org/W2201922795","https://openalex.org/W281082249","https://openalex.org/W2128412585","https://openalex.org/W2135272897","https://openalex.org/W4322724328","https://openalex.org/W171871556","https://openalex.org/W2148820749","https://openalex.org/W2416999743","https://openalex.org/W109492528","https://openalex.org/W2106415917"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}